153 related articles for article (PubMed ID: 9549228)
1. Lupus humoral autoimmunity induced in a primate model by short peptide immunization.
Arbuckle MR; Gross T; Scofield RH; Hinshaw LB; Chang AC; Taylor FB; Harley JB; James JA
J Investig Med; 1998 Feb; 46(2):58-65. PubMed ID: 9549228
[TBL] [Abstract][Full Text] [Related]
2. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.
James JA; Harley JB
J Immunol; 1998 Jan; 160(1):502-8. PubMed ID: 9552009
[TBL] [Abstract][Full Text] [Related]
3. A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif.
Arbuckle MR; Schilling AR; Harley JB; James JA
J Autoimmun; 1998 Oct; 11(5):431-8. PubMed ID: 9802926
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a peptide of Sm B/B' results in limited epitope spreading but not autoimmune disease.
Mason LJ; Timothy LM; Isenberg DA; Kalsi JK
J Immunol; 1999 May; 162(9):5099-105. PubMed ID: 10227979
[TBL] [Abstract][Full Text] [Related]
5. Linear epitope mapping of an Sm B/B' polypeptide.
James JA; Harley JB
J Immunol; 1992 Apr; 148(7):2074-9. PubMed ID: 1372022
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity.
James JA; Gross T; Scofield RH; Harley JB
J Exp Med; 1995 Feb; 181(2):453-61. PubMed ID: 7530756
[TBL] [Abstract][Full Text] [Related]
7. Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies.
James JA; McClain MT; Koelsch G; Williams DG; Harley JB
J Autoimmun; 1999 Feb; 12(1):43-9. PubMed ID: 10028021
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody specific to a subclass of polyproline-Arg motif provides evidence for the presence of an snRNA-free spliceosomal Sm protein complex in vivo: implications for molecular interactions involving proline-rich sequences of Sm B/B' proteins.
Filali M; Qiu J; Awasthi S; Fischer U; Monos D; Kamoun M
J Cell Biochem; 1999 Aug; 74(2):168-80. PubMed ID: 10404387
[TBL] [Abstract][Full Text] [Related]
9. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera.
Hirakata M; Craft J; Hardin JA
J Immunol; 1993 Apr; 150(8 Pt 1):3592-601. PubMed ID: 7682245
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.
Homma M; Mimori T; Takeda Y; Akama H; Yoshida T; Ogasawara T; Akizuki M
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():188-93. PubMed ID: 2441045
[TBL] [Abstract][Full Text] [Related]
11. A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.
Riemekasten G; Marell J; Trebeljahr G; Klein R; Hausdorf G; Häupl T; Schneider-Mergener J; Burmester GR; Hiepe F
J Clin Invest; 1998 Aug; 102(4):754-63. PubMed ID: 9710444
[TBL] [Abstract][Full Text] [Related]
12. Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83-119 peptide in systemic lupus erythematosus and other autoimmune diseases.
Jaekel HP; Klopsch T; Benkenstein B; Grobe N; Baldauf A; Schoessler W; Werle E
J Autoimmun; 2001 Dec; 17(4):347-54. PubMed ID: 11771960
[TBL] [Abstract][Full Text] [Related]
13. Heterologous expression and epitope mapping of a human small nuclear ribonucleoprotein-associated Sm-B'/B autoantigen.
Rokeach LA; Jannatipour M; Hoch SO
J Immunol; 1990 Feb; 144(3):1015-22. PubMed ID: 1688587
[TBL] [Abstract][Full Text] [Related]
14. Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core proteins.
Satoh M; Richards HB; Hamilton KJ; Reeves WH
J Immunol; 1997 May; 158(10):5017-25. PubMed ID: 9144522
[TBL] [Abstract][Full Text] [Related]
15. Identification of an acidic ribosomal protein reactive with anti-Sm autoantibody.
Nojima Y; Minota S; Yamada A; Takaku F
J Immunol; 1989 Sep; 143(6):1915-20. PubMed ID: 2778317
[TBL] [Abstract][Full Text] [Related]
16. Mapping of SLE-specific Sm B cell epitopes using murine monoclonal antibodies.
Pruijn GJ; Schoute F; Thijssen JP; Smeenk RJ; van Venrooij WJ
J Autoimmun; 1997 Apr; 10(2):127-36. PubMed ID: 9185874
[TBL] [Abstract][Full Text] [Related]
17. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs).
Vlachoyiannopoulos PG; Petrovas C; Tzioufas AG; Alexopoulos C; Tsikaris V; Guialis A; Nakopoulou L; Sakarellos-Daitsiotis M; Sakarellos C; Davaris P; Moutsopoulos HM
J Autoimmun; 2000 Feb; 14(1):53-61. PubMed ID: 10648116
[TBL] [Abstract][Full Text] [Related]
18. Anti-Sm and anti-RNP antibodies.
Migliorini P; Baldini C; Rocchi V; Bombardieri S
Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
[TBL] [Abstract][Full Text] [Related]
19. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE.
McClain MT; Scofield RH; Kurien BT; Gross TF; James JA
Scand J Immunol; 2002 Oct; 56(4):399-407. PubMed ID: 12234261
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
